Dunsire Deborah

CIK 00013327646 companiesIRVING, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001332764

Recent Transactions

50 trades

Award
MCKESSON CORP$MCK
Restricted Stock Units (RSUs)
2026-07-22+277→ 277 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2026-05-14+7,751→ 38,566 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2026-05-14+14,058→ 14,058 total
Award
MCKESSON CORP$MCK
Restricted Stock Units (RSUs)
2025-07-30+301→ 301 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2025-05-15+5,740→ 30,815 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2025-05-15+10,787→ 10,787 total
Award
MCKESSON CORP$MCK
Restricted Stock Units (RSUs)
2024-07-31+349→ 349 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2024-06-18+5,345→ 25,075 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2024-06-18+9,900→ 9,900 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2024-06-05+6,000→ 6,000 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-06-05+4,000→ 4,000 total
Award
MCKESSON CORP$MCK
Restricted Stock Units (RSUs)
2024-06-03+56→ 56 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-06-01−4,000→ 0 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-06-01+4,000→ 12,000 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2023-06-07+7,110→ 7,110 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-06-07+3,860→ 19,730 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-01+6,000→ 6,000 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-06-01+4,000→ 4,000 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2022-09-16+8,000→ 8,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-09-16+12,000→ 12,000 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2022-06-24+6,245→ 6,245 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-06-24+3,300→ 15,870 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-06-01+17,500→ 17,500 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2021-09-09+35,000→ 35,000 total
Disposition to Issuer
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2021-07-21−14,629→ 0 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common stock
2021-06-24+2,145→ 12,570 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2021-06-24+4,125→ 4,125 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2021-05-20+533→ 14,629 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2021-05-20+1,962→ 14,096 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2020-06-26+2,550→ 10,425 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2020-06-26+4,250→ 4,250 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2020-05-14+941→ 12,134 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2020-05-14+3,468→ 11,193 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2019-06-11+3,000→ 7,875 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2019-06-11+5,000→ 5,000 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2019-05-15+2,726→ 6,985 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2019-05-15+740→ 7,725 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2018-06-19+5,000→ 5,000 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2018-06-19+3,000→ 4,875 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2018-05-09+2,174→ 4,259 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2018-02-08+2,085→ 2,085 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Employee Stock Option (Right to Buy)
2017-06-22+3,750→ 3,750 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2017-06-22+1,875→ 1,875 total
Award
Ultragenyx Pharmaceutical Inc.$RARE
Stock Option (Right to Buy)
2017-04-06+15,000→ 15,000 total
Exercise/Conversion
ALLERGAN INC
Phantom Stock Units
2015-03-17−8,859.73→ 0 total
Exercise/Conversion
ALLERGAN INC
Common Stock
2015-03-17+8,859.73→ 43,040.73 total
Disposition to Issuer
ALLERGAN INC
Nonemployee Director Stock Option (Right to Buy)
2015-03-17−11,400→ 0 total
Disposition to Issuer
ALLERGAN INC
Nonemployee Director Stock Option (Right to Buy)
2015-03-17−11,400→ 0 total
Disposition to Issuer
ALLERGAN INC
Common Stock
2015-03-17−43,040.73→ 0 total
Disposition to Issuer
ALLERGAN INC
Nonemployee Director Stock Option (Right to Buy)
2015-03-17−11,400→ 0 total

Companies

Recent Filings

Address

6555 NORTH STATE HWY 161

IRVING, TX, 75039

View on SEC.gov